Gut dysfunction in patients with active IBD may be connected with changes in many factors, for instance increased prostaglandin levels as a result of COX-2 overexpression in neural cells of the myenteric plexus or decreased opioid peptides level rapidly degraded by endogenous enzymes (NEP, APN, DPPIII, and ACE). Here, DPP3 is linked to inflammatory bowel disease.